Search research articles
Contact Us
Filters
Showing results (371-380 of 385) with videos related to
Page
of 39
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 4, 2007
Multidrug resistance proteins do not predict benefit of adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: International Adjuvant Lung Cancer Trial Biologic Program
Martin Filipits, Vincent Haddad, Katharina Schmid, et al.
Thorax
|
December 19, 2007
EGFR and PDGFR differentially promote growth in malignant epithelioid mesothelioma of short and long term survivors
H Kothmaier, F Quehenberger, I Halbwedl, et al.
Human Pathology
|
May 13, 2004
Atypical goblet cell hyperplasia in congenital cystic adenomatoid malformation as a possible preneoplasia for pulmonary adenocarcinoma in childhood: A genetic analysis
Elvira Stacher, Reinhard Ullmann, Iris Halbwedl, et al.
Hepatology (Baltimore, Md.)
|
May 1, 1981
Antiviral treatment of chronic hepatitis B virus infection: improvement in liver disease with interferon and adenine arabinoside
G H Scullard, L L Andres, H B Greenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 3, 2007
Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program
Martin Filipits, Robert Pirker, Ariane Dunant, et al.
BMC Cancer
|
January 28, 2014
Hypoxia increases membrane metallo-endopeptidase expression in a novel lung cancer ex vivo model - role of tumor stroma cells
Katharina Leithner, Christoph Wohlkoenig, Elvira Stacher, et al.
The New England Journal of Medicine
|
September 8, 2006
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy
Ken A Olaussen, Ariane Dunant, Pierre Fouret, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 29, 2015
Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection
Ming-Sound Tsao, Sophie Marguet, Gwénaël Le Teuff, et al.
Cancer Research
|
October 28, 2010
MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma
Johannes Voortman, Akiteru Goto, Jean Mendiboure, et al.
Theranostics
|
June 7, 2021
Genomic and transcriptional alterations in first-line chemotherapy exert a potentially unfavorable influence on subsequent immunotherapy in NSCLC
Yayi He, Linsong Chen, Lishu Zhao, et al.
Page
of 39
Search research articles
Search
Showing results (371-380 of 385) with videos related to
Sort By:
Page
of 39
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 4, 2007
Multidrug resistance proteins do not predict benefit of adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: International Adjuvant Lung Cancer Trial Biologic Program
Martin Filipits, Vincent Haddad, Katharina Schmid, et al.
Thorax
|
December 19, 2007
EGFR and PDGFR differentially promote growth in malignant epithelioid mesothelioma of short and long term survivors
H Kothmaier, F Quehenberger, I Halbwedl, et al.
Human Pathology
|
May 13, 2004
Atypical goblet cell hyperplasia in congenital cystic adenomatoid malformation as a possible preneoplasia for pulmonary adenocarcinoma in childhood: A genetic analysis
Elvira Stacher, Reinhard Ullmann, Iris Halbwedl, et al.
Hepatology (Baltimore, Md.)
|
May 1, 1981
Antiviral treatment of chronic hepatitis B virus infection: improvement in liver disease with interferon and adenine arabinoside
G H Scullard, L L Andres, H B Greenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 3, 2007
Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program
Martin Filipits, Robert Pirker, Ariane Dunant, et al.
BMC Cancer
|
January 28, 2014
Hypoxia increases membrane metallo-endopeptidase expression in a novel lung cancer ex vivo model - role of tumor stroma cells
Katharina Leithner, Christoph Wohlkoenig, Elvira Stacher, et al.
The New England Journal of Medicine
|
September 8, 2006
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy
Ken A Olaussen, Ariane Dunant, Pierre Fouret, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 29, 2015
Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection
Ming-Sound Tsao, Sophie Marguet, Gwénaël Le Teuff, et al.
Cancer Research
|
October 28, 2010
MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma
Johannes Voortman, Akiteru Goto, Jean Mendiboure, et al.
Theranostics
|
June 7, 2021
Genomic and transcriptional alterations in first-line chemotherapy exert a potentially unfavorable influence on subsequent immunotherapy in NSCLC
Yayi He, Linsong Chen, Lishu Zhao, et al.
Page
of 39